Patents by Inventor Smadar Gertel

Smadar Gertel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING SUITABILITY OF A SUBJECT TO ANTI TNF ALPHA THERAPY
    Publication number: 20240125766
    Abstract: The present invention is directed to a method for determining the suitability of a subject to TNF? inhibitor therapy. Further provide is a method for treating a subject afflicted with a TNF? related disease.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Inventors: Ori ELKAYAM, Smadar GERTEL
  • Synthetic peptides for the treatment of autoimmune diseases
    Patent number: 9975944
    Abstract: The present invention provides synthetic peptides, including peptides comprising a plurality of epitopes, each epitope being derived from a different protein, and peptides comprising a plurality of citrullinated residues. The present invention also related to use of said peptides for the treatment of autoimmune diseases and disorder.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: May 22, 2018
    Assignee: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Yehuda Shoenfeld, Howard Amital, Smadar Gertel
  • SYNTHETIC PEPTIDES FOR THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20160024183
    Abstract: The present invention provides synthetic peptides, including peptides comprising a plurality of epitopes, each epitope being derived from a different protein, and peptides comprising a plurality of citrullinated residues. The present invention also related to use of said peptides for the treatment of autoimmune diseases and disorder.
    Type: Application
    Filed: March 11, 2014
    Publication date: January 28, 2016
    Inventors: Yehuda Shoenfeld, Howard Amital, Smadar Gertel